HIMS to Introduce Compounded GLP-1 Injections, What Plan Sponsors Need to Know Scripta May 28, 2024 3 min read Updated: Jun 14, 2024 Hims & Hers' (HIMS) latest move to introduce compounded GLP-1 injections into its weight loss program is stirring up excitement and raising a few eyebrows among plan sponsors
Check for any cloudiness, particles, or color changes that were not present before the exposure
Compounds that appeared promising in preclinical and early clinical data have failed in later-phase trials repeatedly
The propionate version has been the traditional choice, but enanthate has gained popularity for the convenience of matching injection schedules with testosterone enanthate or cypionate
Let us look at the important aspects of this debate: 2
Short-term predictive indicators that are strongly correlated with clinical outcomes in MASLD are highly anticipated, but reliable surrogate endpoints are currently lacking